References
- Ellertson C, Waldman S N. The mifepristone–misoprostol regimen for early medical abortion. Curr Womens Health Rep 2001; 1: 184–190
- Ashok P W, Penney G C, Flett G M, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod 1998; 13: 2962–2965
- Gynuity Health Projects. Global map of mifepristone approval. Gynuity Health Projects, Inc., New York, NY 2004
- Newhall E P, Winikoff B. Abortion with mifepristone and misoprostol: Regimens, efficacy, acceptability and future directions. Am J Obstet Gynecol 2000; 183: S44–S53
- Clark W H, Hassoun D, Gemzell-Danielson K, Fiala C, Winikoff B. Home use of two doses of misoprostol after mifepristone for medical abortion: A pilot study in Sweden and France. Eur J Contracept Reprod Health Care 2005; 10: 184–191
- El-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Eng J Med 1995; 332: 983–987
- Spitz I M, Bardin C W, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Eng J Med 1998; 338: 1241–1247
- Schaff E A, Eisinger S H, Stadalius L S, Franks P, Gore B Z, Poppema S. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception 1999; 59: 1–6
- Schaff E A, Fielding S L, Eisinger S H, Stadalius L S, Fuller L. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception 2000; 61: 41–46
- Shannon C S, Winikoff B, Hausknecht R, Schaff E, Blumenthal P D, Oyer D, Sankey H, Wolff J, Goldberg R. Multicenter trial of a simplified mifepristone medical abortion regimen. Obstet Gynecol 2005; 105: 345–351
- Ipas. Medical abortion – implications for Africa. Ipas, Chapel Hill, NC 2003
- Benson J, Clark K A, Gerhardt A, Randall L, Dudley S. Early abortion services in the United States: a provider survey. Contraception 2003; 67: 287–294
- Jones R K, Henshaw S K. Mifepristone for early medical abortion: Experiences in France, Great Britain and Sweden. Perspect Sex Reprod Health 2002; 34: 154–161
- Kaiser Family Foundation. Views and practices of women's health care providers on medical abortion: An update on mifepristone. The Henry J. Kaiser Family Foundation, Menlo Park, CA 2001
- Consensus statement: Instructions for use – abortion induction with misoprostol in pregnancies up to 9 weeks LMP. Expert Meeting on Misoprostol sponsored by Reproductive Health Technologies Project and Gynuity Health Projects, Washington, DC, July 28, 2003
- Blanchard K, Winikoff B, Ellertson C. Misoprostol used alone for the termination of early pregnancy. Contraception 1999; 59: 209–217
- Jain J K, Dutton C, Harwood B, Meckstroth K R, Mishell D R. A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol-alone for elective termination of early pregnancy. Human Reprod 2002; 17: 1477–1482